Literature DB >> 408355

An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines.

J M Wood, G C Schild, R W Newman, V Seagroatt.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 408355     DOI： 10.1016/s0092-1157(77)80008-5

Source DB:  PubMed          Journal:  J Biol Stand        ISSN： 0092-1157


× No keyword cloud information.
  68 in total

1.  Quantification of viral proteins of the avian H7 subtype of influenza virus: an isotope dilution mass spectrometry method applicable for producing more rapid vaccines in the case of an influenza pandemic.

Authors:  Wanda I Santana; Tracie L Williams; Emily K Winne; James L Pirkle; John R Barr
Journal:  Anal Chem       Date:  2014-04-11       Impact factor: 6.986

2.  Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses.

Authors:  Otfried Kistner; M Keith Howard; Martin Spruth; Walter Wodal; Peter Brühl; Marijan Gerencer; Brian A Crowe; Helga Savidis-Dacho; Ian Livey; Manfred Reiter; Ines Mayerhofer; Christa Tauer; Leopold Grillberger; Wolfgang Mundt; Falko G Falkner; P Noel Barrett
Journal:  Vaccine       Date:  2007-06-04       Impact factor: 3.641

3.  Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules.

Authors:  Ruth Harvey; Kate A Guilfoyle; Sarah Roseby; James S Robertson; Othmar G Engelhardt
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

4.  Mucosal immunoadjuvant activity of liposomes: role of alveolar macrophages.

Authors:  A de Haan; G Groen; J Prop; N van Rooijen; J Wilschut
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

5.  Dose sparing and the lack of a dose-response relationship with an influenza vaccine in adult and elderly patients - a randomized, double-blind clinical trial.

Authors:  Zoltan Vajo; Gergely Balaton; Peter Vajo; Laszlo Kalabay; Adam Erdman; Peter Torzsa
Journal:  Br J Clin Pharmacol       Date:  2017-04-11       Impact factor: 4.335

6.  Depressed chemiluminescence response by influenza virus is enhanced after conjugation of viral subunits to muramyl dipeptide.

Authors:  K N Masihi; W Lange; B Rohde-Schulz; L Chedid; M Jolivet
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development.

Authors:  Zoltan Vajo; John Wood; Lajos Kosa; Istvan Szilvasy; Gyorgy Paragh; Zsuzsanna Pauliny; Kálmán Bartha; Ildiko Visontay; Agnes Kis; Istvan Jankovics
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

8.  Limited Tryptic Digestion-Isotope Dilution Mass Spectrometry (LTD-IDMS): A Reagent-Free Analytical Assay To Quantify Hemagglutinin of A(H5N1) Vaccine Material.

Authors:  Hans C Cooper; Yuhong Xie; Giuseppe Palladino; John R Barr; Ethan C Settembre; Yingxia Wen; Tracie L Williams
Journal:  Anal Chem       Date:  2020-08-12       Impact factor: 6.986

Review 9.  Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing.

Authors:  John S Oxford
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

10.  A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

Authors:  Otfried Kistner; Brian A Crowe; Walter Wodal; Astrid Kerschbaum; Helga Savidis-Dacho; Nicolas Sabarth; Falko G Falkner; Ines Mayerhofer; Wolfgang Mundt; Manfred Reiter; Leopold Grillberger; Christa Tauer; Michael Graninger; Alois Sachslehner; Michael Schwendinger; Peter Brühl; Thomas R Kreil; Hartmut J Ehrlich; P Noel Barrett
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.